Non-Pedicled Buccal Fat Pad Graft in the Treatment of Gingival Recessions (NCT02393053) | Clinical Trial Compass
CompletedNot Applicable
Non-Pedicled Buccal Fat Pad Graft in the Treatment of Gingival Recessions
12 participantsStarted 2010-11
Plain-language summary
Background: This randomized controlled clinical study of split-mouth aimed to compare non-pedicled buccal fat pad graft (BFPG) with subepithelial connective tissue graft (SCTG) in the treatment of Miller Class I or II gingival recessions.
Methods: Twelve patients with Miller Class I or II (≥ 2 mm) bilateral recessions in maxillary premolars or canines were selected. The recessions were randomly assigned to receive SCTG (Control Group) or BFPG (Test Group). The clinical parameters of Gingival Index (GI), Plaque Index (PI), Probing Depth (PD), Gingival Recession (GR), Clinical Attachment Level (CAL), Width of Keratinized Tissue (WKT), Thickness of Keratinized Tissue (TKT) and Gingival Margin to the Acrylic Guide (GM-AG) were evaluated at baseline, and in the postoperative periods of 1, 3, and 6 months. The percentage of root coverage was also evaluated. Data were submitted to repeated measures ANOVA, Bonferroni method and t-test (p\<0.05).
Who can participate
Age range
21 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients with Miller Class I or II gingival recessions located bilaterally in the vestibular surface of upper premolars or canines ≥ to 2 mm
. Patients who had recessions with some differences between the right and the left sides ≤ to 3 mm
. Non-smokers
. Non-pregnant patients
. Systemically healthy patients
. Periodontally healthy patients with no contraindications for periodontal surgery
. Patients who did not take any kind of medicine that could interfere with the health of gingival and periodontal tissue
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Probing Depth (PD)
Timeframe: Baseline, 1, 3, and 6 months respectively
2
Change in Gingival Recession (GR)
Timeframe: Baseline, 1, 3, and 6 months respectively
3
Change in Clinical Attachment Level (CAL)
Timeframe: Baseline, 1, 3, and 6 months respectively
4
Change in Width of Keratinized Tissue (WKT)
Timeframe: Baseline, 1, 3, and 6 months respectively
5
Change in Thickness of Keratinized Tissue (TKT)
Timeframe: Baseline, 1, 3, and 6 months respectively